Tag: NASDAQ:VVUS

Finance

Healthcare Stocks Touched New Lows: VIVUS (NASDAQ:VVUS), Akebia Therapeutics Inc (NASDAQ:AKBA), Versartis Inc (NASDAQ:VSAR), BioLife Solutions (NASDAQ:BLFS)

VIVUS Inc. (NASDAQ:VVUS) lower following news late Tuesday night that three directors — J. Martin Carroll, Mark B. Logan and Robert N. Wilson — will not stand for re-election to the company’s Board. This will be the sixth-straight session for the stock to close lower. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 0.20% in last session and finished the day at $5.00. Traded volume was 2.64million … Continue reading Healthcare Stocks Touched New Lows: VIVUS (NASDAQ:VVUS), Akebia Therapeutics Inc (NASDAQ:AKBA), Versartis Inc (NASDAQ:VSAR), BioLife Solutions (NASDAQ:BLFS)

Kristen Barton
Finance

Biotech New Lows: VIVUS (NASDAQ:VVUS), Dipexium Pharmaceuticals (NASDAQ:DPRX), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Galmed Pharmaceuticals (NASDAQ:GLMD)

VIVUS, Inc. (NASDAQ:VVUS) announced that Shari Belafonte is teaming up with the company to educate American adults about seeking medical treatment for chronic weight management when diet and physical activity alone have not been successful. Ms. Belafonte, an actress, model, photographer, writer, singer and daughter of famed musician and actor Harry Belafonte, knows that the impact of being overweight is more than superficial. VIVUS, Inc. … Continue reading Biotech New Lows: VIVUS (NASDAQ:VVUS), Dipexium Pharmaceuticals (NASDAQ:DPRX), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Galmed Pharmaceuticals (NASDAQ:GLMD)

Chris Lewis
FB Nasdaq FB Facebook
BioTech

Biotech Active Runners: Novavax (NASDAQ:NVAX), VIVUS (NASDAQ:VVUS), Rexahn Pharmaceuticals (NYSEMKT:RNN), Ariad Pharmaceuticals (NASDAQ:ARIA)

Novavax, Inc. (NASDAQ:NVAX), announced on Thursday that the Biomedical Advanced Research and Development authority extended the base period of performance of a contract with the pharmaceutical company for its recombinant seasonal and pandemic influenza vaccines. Novavax, Inc. (NASDAQ:NVAX) stock performance was 1.27% in last session and finished the day at $6.38. Traded volume was 13,436,282 million shares in the last session and the average volume … Continue reading Biotech Active Runners: Novavax (NASDAQ:NVAX), VIVUS (NASDAQ:VVUS), Rexahn Pharmaceuticals (NYSEMKT:RNN), Ariad Pharmaceuticals (NASDAQ:ARIA)

Colin Pettis
BioTech

Biotech Runners: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

VIVUS Inc. (NASDAQ:VVUS) stock was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $8.00 price target on the stock, down previously from $15.00. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 1.00% in last session and finished the day at $6.09. Traded volume was 5,364,675 million shares in the last session and the average volume … Continue reading Biotech Runners: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Mark DeFrance